Lake Street analyst Frank Takkinen reiterated a Buy rating on Pulmonx (LUNG – Research Report) today and set a price target of $12.00. The company’s shares closed yesterday at $6.83.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback